Home Cart Sign in  
Chemical Structure| 1448346-63-1 Chemical Structure| 1448346-63-1

Structure of IDH1 Inhibitor 8
CAS No.: 1448346-63-1

Chemical Structure| 1448346-63-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AG-120 Racemate is the racemate form of AG-120 with no activity.

Synonyms: AG-120; racemic

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IDH1 Inhibitor 8

CAS No. :1448346-63-1
Formula : C28H22ClF3N6O3
M.W : 582.96
SMILES Code : O=C([C@H](CC1)N(C2=NC=CC(C#N)=C2)C1=O)N(C(C3=CC=CC=C3Cl)C(NC4CC(F)(F)C4)=O)C5=CC(F)=CN=C5
Synonyms :
AG-120; racemic
MDL No. :MFCD29044889
InChI Key :WIJZXSAJMHAVGX-XADRRFQNSA-N
Pubchem ID :89699486

Safety of IDH1 Inhibitor 8

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03503409 Myelodysplastic Syndromes|Acut... More >>e Myeloid Leukemia Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-04-02 CH Angers, Angers, 49933, Fran... More >>ce|Centre Hospitalier de la C?te Basque, Bayonne, 64109, France|H?pital Nord Franche-Comté/Service de médecine interne / Hématologie clinique, Belfort, 90015, France|CHU c?te de Nacre, Caen, 14033, France|CHU de Grenoble/Clinique Universitaire d'hématologie 6e A, Grenoble, 38043, France|CH Le Mans/Service d'hématologie Oncologie, Le Mans, 72000, France|CHRU de Limoges, Limoges, 87046, France|centre hospitalier de Lyon, Lyon, 69495, France|Institut Paoli Calmettes/Unité d'Hématologie 3, Marseille, 13273, France|CHU Montpellier St Eloi, Montpellier, 34295, France|H?pital E. Muller-GHR Mulhouse Sud-Alsace, Mulhouse, 68100, France|CHU H?tel Dieu/Service d'Hématologie Clinique, Nantes, 44093, France|H?pital Archet 1/Service d'Hématologie Clinique, Nice, 06200, France|GHU Caremeau, Nimes, 30029, France|H?pital Saint Louis - Hématologie Séniors, Paris, 75010, France|H?pital Necker, Paris, 75743, France|H?pital Henri Mondor, Paris, 94010, France|CHU de Haut-Lévèque/Centre Fran?ois Magendie/Service des maladies du sang, Pessac, 33604, France|CHU de Poitiers/P?le de cancérologie - secteur tertiaire-, Poitiers, 86021, France|Centre Henri Becquerel, Rouen, 76038, France|institut de cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, 42271, France|Médecine Interne/IUCT Oncopole, Toulouse, 31059, France|CHU de Tours, Tours, 37044, France|CHU Brabois, Vand?uvre-lès-Nancy, 54511, France|Centre Hospitalier de Versailles-H?pital André Mignot, Versailles, 78157, France|Ematologia ALESSANDRIA, Alessandria, 16115121, Italy|CLINICA Ematologica ANCONA, Ancona, 7160126, Italy|Ematologia BOLOGNA, Bologna, 40138, Italy|Ematologia BRESCIA, Brescia, 125123, Italy|Ematologia FIRENZE, Firenze, 350134, Italy|Clinica Ematologica Genova, Genova, 1016132, Italy|Ematologia GENOVA, Genova, 1016132, Italy|Ematologia LECCE, Lecce, 73100, Italy|Ematologia MILANO, Milano, 3520122, Italy|Ematologia ORBASSANO, Orbassano, 1010043, Italy|Ematologia ed Immunologia Clinica PADOVA, Padova, 235128, Italy|Reggio Calabria, Reggio Calabria, 2189124, Italy|Ematologia ROMA, Roma, 1000144, Italy Less <<
NCT02074839 Relapsed or Refractory Acute M... More >>yeloid Leukemia (AML)|Untreated AML|Other IDH1-mutated Positive Hematologic Malignancies|Myelodysplastic Syndromes Less << PHASE1 RECRUITING 2025-08-25 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Mayo Clinic-AZ, Phoenix, Arizona, 85259, United States|City of Hope, Duarte, California, 91010, United States|University of California-Los Angeles, Los Angeles, California, 90095, United States|University of California-San Francisco, San Francisco, California, 94143, United States|University of Colorado Denver, Aurora, Colorado, 80045, United States|Mayo Clinic-Jacksonville, Jacksonville, Florida, 32224, United States|University of Miami, Miami, Florida, 33136, United States|Moffit Cancer Center, Tampa, Florida, 33612, United States|Emory University, Atlanta, Georgia, 30322, United States|Northwestern University Medical Hospital, Chicago, Illinois, 60611, United States|John Hopkins Cancer Center, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Center, Detroit, Michigan, 48201, United States|Washington University, Saint Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States|Cornell Cancer Center, New York, New York, 10065, United States|Duke Cancer Center, Durham, North Carolina, 27705, United States|Cleveland Clinic, Cleveland, Ohio, 44124, United States|Ohio State University, Columbus, Ohio, 43210, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Hopital La Timone, Marseille, France|Hopital Haut-Leveque, Pessac, 33600, France|Central Lyon Sud, Pierre-Bénite, 69310, France|Institute Gustave Roussly (IGR), Villejuif, 94800, France Less <<
NCT02073994 Cholangiocarcinoma|Chondrosarc... More >>oma|Glioma|Other Advanced Solid Tumors Less << PHASE1 COMPLETED 2024-01-04 Scottsdale, Arizona, 85258, Un... More >>ited States|Los Angeles, California, 90095, United States|Aurora, Colorado, 80045, United States|Miami, Florida, 33136, United States|Baltimore, Maryland, 21218, United States|Boston, Massachusetts, 02215, United States|New York, New York, 10065, United States|Nashville, Tennessee, 37203, United States|Dallas, Texas, 75390, United States|Houston, Texas, 77030, United States|San Antonio, Texas, 78229, United States|Villejuif, 94800, France Less <<
NCT04278781 Chondrosarcoma|Chondrosarcoma,... More >> Grade 2|Chondrosarcoma, Grade 3|IDH1 Gene Mutation Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-03-26 Johns Hopkins Hospital (Data C... More >>ollection Only), Baltimore, Maryland, 21287, United States|Columbia University (Specimen Analysis Only), New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|The Ohio State University (Data Collection Only), Columbus, Ohio, 43210, United States|MD Anderson Cancer Center (Data Collection Only), Houston, Texas, 77030, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.58mL

1.72mL

0.86mL

17.15mL

3.43mL

1.72mL

References

 

Historical Records

Categories